Krystal Biotech grants director 1,658-share award
Krystal Biotech granted its director a package of stock options and RSUs that fully vest in 2027, aligning compensation with future board service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Krystal Biotech, Inc. (KRYS) reported that director Julian S. Gangolli received equity awards on September 14, 2026. He was granted 1,187 stock options with an exercise price of $340.03 per share, expiring on September 13, 2036, and 471 restricted stock units. Both the options and RSUs vest in full on September 14, 2027, subject to his continued service on the Board and earlier vesting conditions under the company’s Non-Employee Director Compensation Policy.
Insider Trade Summary
Grant/Award: 1,658 shares
Grant/Award
2 txns
Insider
Gangolli Julian S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 1,187 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units F2, F3 | 471 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,187 contracts (Direct);
Restricted Stock Units — 471 contracts (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 1,187 contracts (Direct);
Restricted Stock Units, 0 to 471 contracts (Direct)
Footnotes (3)
- F1. The stock options vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- F3. The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant.
Key Figures
Stock options granted: 1,187 options
Option exercise price: $340.03 per share
Option expiration date: September 13, 2036
+4 more
7 metrics
Stock options granted
1,187 options
Grant to director on September 14, 2026
Option exercise price
$340.03 per share
Exercise price for 1,187 stock options granted
Option expiration date
September 13, 2036
Expiration of granted stock options
RSUs granted
471 RSUs
Grant to director on September 14, 2026
Vesting date for awards
September 14, 2027
Full vesting date for both options and RSUs, subject to continued service
Shares underlying options
1,187 shares
Common stock underlying the granted stock options
Shares underlying RSUs
471 shares
Common stock underlying the granted RSUs
Key Terms
Restricted Stock Units, Non-Employee Director Compensation Policy, Stock Option
3 terms
Restricted Stock Units financial
"The RSUs vest in full on September 14, 2027, subject to continued service"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Non-Employee Director Compensation Policy financial
"described in the Company's Non-Employee Director Compensation Policy as in effect"
Stock Option financial
"The stock options vest in full on September 14, 2027, subject to continued service"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did KRYS grant to director Julian S. Gangolli?
Krystal Biotech granted 1,187 stock options with a $340.03 exercise price and 471 RSUs to director Julian S. Gangolli on September 14, 2026, all tied to the company’s common stock.
When do the new stock options and RSUs for KRYS director vest?
Both the 1,187 stock options and 471 RSUs vest in full on September 14, 2027, subject to Mr. Gangolli’s continued service on Krystal Biotech’s Board of Directors and earlier vesting in certain circumstances under the Non-Employee Director Compensation Policy.
What is the exercise price and expiration date of the KRYS stock options granted?
The stock options granted to Julian S. Gangolli have an exercise price of $340.03 per share and an expiration date of September 13, 2036, providing a long-dated right to purchase Krystal Biotech common stock if vested.
Are the KRYS director equity awards tied to a Rule 10b5-1 plan?
No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that these awards were granted pursuant to a Rule 10b5-1 trading plan.
What does each KRYS restricted stock unit represent for the director?
Each restricted stock unit (RSU) granted to Julian S. Gangolli represents a contingent right to receive one share of Krystal Biotech’s common stock, subject to the vesting conditions described, including continued service on the Board through September 14, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
